KT203
KT195[edit | edit source]
KT195 is a chemical compound that has been studied for its potential therapeutic effects and its role as a biochemical tool in research. It is known for its ability to inhibit certain enzymes, making it a valuable compound in the study of biochemical pathways and disease mechanisms.
Chemical Structure and Properties[edit | edit source]
KT195 is a small molecule inhibitor with a specific chemical structure that allows it to interact with target enzymes. The molecular formula of KT195 is C₁₉H₂₁N₃O₃, and it has a molecular weight of 339.39 g/mol. The compound is characterized by its aromatic rings and functional groups that facilitate binding to enzyme active sites.
Mechanism of Action[edit | edit source]
KT195 functions primarily as an inhibitor of serine hydrolases, a class of enzymes that play critical roles in various biological processes, including metabolism, signal transduction, and inflammation. By inhibiting these enzymes, KT195 can modulate biochemical pathways, providing insights into their functions and potential therapeutic targets.
Research Applications[edit | edit source]
KT195 has been utilized in various research studies to explore its effects on metabolic pathways and disease models. It has been particularly useful in the study of cancer, where it helps to elucidate the role of serine hydrolases in tumor growth and progression. Additionally, KT195 has been used in the development of diagnostic tools and as a lead compound in drug discovery efforts.
Potential Therapeutic Uses[edit | edit source]
While KT195 is primarily a research tool, its ability to inhibit specific enzymes suggests potential therapeutic applications. Research is ongoing to determine its efficacy and safety in treating diseases such as cancer, metabolic disorders, and inflammatory conditions.
Safety and Toxicology[edit | edit source]
As with any chemical compound, the safety and toxicological profile of KT195 must be thoroughly evaluated. Studies have been conducted to assess its cytotoxicity, bioavailability, and potential side effects. These studies are crucial for determining the feasibility of KT195 as a therapeutic agent.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
